Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4597369018 | Belumosudil (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4597370017 | Belumosudil | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5270991000052111 | belumosudil | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belumosudil (substance) | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Belumosudil (substance) | Is a | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some | ||
| Belumosudil (substance) | Has disposition (attribute) | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Belumosudil mesilate | Is modification of (attribute) | True | Belumosudil (substance) | Inferred relationship | Some | |
| Belumosudil-containing product in oral dose form | Has active ingredient | True | Belumosudil (substance) | Inferred relationship | Some | 1 |
| Product containing only belumosudil in oral dose form (medicinal product form) | Has active ingredient | True | Belumosudil (substance) | Inferred relationship | Some | 1 |
| Product containing belumosudil (medicinal product) | Has active ingredient | True | Belumosudil (substance) | Inferred relationship | Some | 1 |
| Product containing only belumosudil (medicinal product) | Has active ingredient | True | Belumosudil (substance) | Inferred relationship | Some | 1 |
| Product containing precisely belumosudil (as belumosudil mesilate) 200 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Belumosudil (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR